{"schema_version":"secwatch.filing_event.v1","accession":"0001111928-26-000094","form_type":"8-K","ticker":"IPGP","cik":"0001111928","company_name":"IPG PHOTONICS CORP","filed_at":"2026-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:31.969527+00:00","generated_at":"2026-05-14T23:13:12.858893+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"IPG Photonics Q1 revenue up 17% to $265.5M; settles global patent litigation with Trumpf","bullets":["Revenue $265.5M (+17% YoY); GAAP diluted EPS $0.04, adjusted EPS $0.29.","Industrial Solutions sales up 21% YoY; Advanced Solutions down 5%.","Q2 guidance: revenue $260-290M, adjusted EPS $0.25-0.55, adjusted EBITDA $32-48M.","Book-to-bill above one for second consecutive quarter; demand robust.","Resolved and dismissed all patent litigation with Trumpf worldwide; terms not disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001111928-26-000094","json":"https://secwatch.observer/filing/0001111928-26-000094.json","markdown":"https://secwatch.observer/filing/0001111928-26-000094.md","text":"https://secwatch.observer/filing/0001111928-26-000094.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1111928/000111192826000094/0001111928-26-000094-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1111928/000111192826000094/ipgp-20260505.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T23:13:12.858893+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c7b1359f53932755199b5f8dee9df02bafd7a7b2","claim":"IPG PHOTONICS CORP reported first quarter ended March 31, 2026 results: revenue $265.5, net income $1.6, EPS $0.04. Guidance initiated.","evidence_excerpt":"Three Months Ended March 31, (In millions, except per share data and percentages) 2026 2025 Change Revenue $ 265.5 $ 227.8 17 % Gross margin 37.5 % 39.4 % Operating income (loss) $ (7.7) $ 1.8 NM Operating margin (2.9) % 0.8 % Net income $ 1.6 $ 3.8 (58) % Earnings per diluted share $ 0.04 $ 0.09 (56) %","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1111928/000111192826000094/0001111928-26-000094-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001193125-26-213239","ticker":"ARTV","company_name":"Artiva Biotherapeutics, Inc.","filed_at":"2026-05-08T23:59:59+00:00","headline":"Artiva reports 71% ACR50 in refractory RA at 6 months, FDA alignment for Phase 3 trial; Q1 net loss $23.5M","event_type":"other_material","sec_items":["2.02","7.01","8.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 8.01, 9.01","same event type: other_material"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-213239","json":"https://secwatch.observer/filing/0001193125-26-213239.json","markdown":"https://secwatch.observer/filing/0001193125-26-213239.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1817241/000119312526213239/0001193125-26-213239-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1817241/000119312526213239/d38160d8k.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"Three Months Ended March 31, (In millions, except per share data and percentages) 2026 2025 Change Revenue $ 265.5 $ 227.8 17 % Gross margin 37.5 % 39.4 % Operating income (loss) $ (7.7) $ 1.8 NM Operating margin (2.9) % 0.8 % Net income $ 1.6 $ 3.8 (58) % Earnings per diluted share $ 0.04 $ 0.09 (56) %","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1111928/000111192826000094/0001111928-26-000094-index.htm","comparable_excerpt":"Artiva Biotherapeutics, Inc. (the \"Company\") issued a press release announcing its financial results for the quarter ended March 31, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312526213239/0001193125-26-213239-index.htm"}},{"accession":"0001628280-26-039786","ticker":"YEXT","company_name":"Yext, Inc.","filed_at":"2026-06-02T20:05:58+00:00","headline":"Yext Q1 FY27: Adj EBITDA margin 25%, ARR $440.8M; boosts buyback by $100M","event_type":"earnings","sec_items":["2.02","8.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 8.01, 9.01","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-039786","json":"https://secwatch.observer/filing/0001628280-26-039786.json","markdown":"https://secwatch.observer/filing/0001628280-26-039786.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1614178/000162828026039786/0001628280-26-039786-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1614178/000162828026039786/yext-20260602.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"Three Months Ended March 31, (In millions, except per share data and percentages) 2026 2025 Change Revenue $ 265.5 $ 227.8 17 % Gross margin 37.5 % 39.4 % Operating income (loss) $ (7.7) $ 1.8 NM Operating margin (2.9) % 0.8 % Net income $ 1.6 $ 3.8 (58) % Earnings per diluted share $ 0.04 $ 0.09 (56) %","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1111928/000111192826000094/0001111928-26-000094-index.htm","comparable_excerpt":"Exchange Act, except as expressly set forth by specific reference in such a filing. \n\n--- EX-99.1 (EX-99.1) ---\n\nYext Announces First Quarter Fiscal 2027 Results – Revenue of $107.9 million – Net Income Per Share, basic, of $0.02 or non-GAAP Net Income Per Share of $0.15 – Adjusted EBITDA of $26.9 million, resulting in an Adjusted EBITDA margin of 25% – ARR of","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1614178/000162828026039786/0001628280-26-039786-index.htm"}},{"accession":"0001043000-26-000016","ticker":"SNDA","company_name":"SONIDA SENIOR LIVING, INC.","filed_at":"2026-05-11T23:59:59+00:00","headline":"Sonida Senior Living reports Q1 net loss of $41.2M; revenue up 37% on CHP acquisition","event_type":"earnings","sec_items":["2.02","8.01","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 8.01, 9.01","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001043000-26-000016","json":"https://secwatch.observer/filing/0001043000-26-000016.json","markdown":"https://secwatch.observer/filing/0001043000-26-000016.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1043000/000104300026000016/0001043000-26-000016-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1043000/000104300026000016/snda-20260511.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"Three Months Ended March 31, (In millions, except per share data and percentages) 2026 2025 Change Revenue $ 265.5 $ 227.8 17 % Gross margin 37.5 % 39.4 % Operating income (loss) $ (7.7) $ 1.8 NM Operating margin (2.9) % 0.8 % Net income $ 1.6 $ 3.8 (58) % Earnings per diluted share $ 0.04 $ 0.09 (56) %","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1111928/000111192826000094/0001111928-26-000094-index.htm","comparable_excerpt":"Sonida Senior Living Announces First Quarter 2026 Results DALLAS, Texas – May 11, 2026 – Sonida Senior Living, Inc. (the “Company,” “Sonida,” “we,” “our,” or “us”) (NYSE: SNDA), a leading owner, operator and investor of senior housing communities, today announced its results for the first quarter ended March 31, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1043000/000104300026000016/0001043000-26-000016-index.htm"}},{"accession":"0001193125-26-215674","ticker":"LXEO","company_name":"Lexeo Therapeutics, Inc.","filed_at":"2026-05-11T23:59:59+00:00","headline":"Lexeo Therapeutics Q1 net loss $20.2M; cash $227.6M; LX2006 pivotal trial protocol submitted to FDA","event_type":"earnings","sec_items":["2.02","8.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 8.01, 9.01","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-215674","json":"https://secwatch.observer/filing/0001193125-26-215674.json","markdown":"https://secwatch.observer/filing/0001193125-26-215674.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1907108/000119312526215674/0001193125-26-215674-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1907108/000119312526215674/lxeo-20260511.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"Three Months Ended March 31, (In millions, except per share data and percentages) 2026 2025 Change Revenue $ 265.5 $ 227.8 17 % Gross margin 37.5 % 39.4 % Operating income (loss) $ (7.7) $ 1.8 NM Operating margin (2.9) % 0.8 % Net income $ 1.6 $ 3.8 (58) % Earnings per diluted share $ 0.04 $ 0.09 (56) %","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1111928/000111192826000094/0001111928-26-000094-index.htm","comparable_excerpt":"Lexeo Therapeutics Reports First Quarter 2026 Financial Results and Operational Highlights","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1907108/000119312526215674/0001193125-26-215674-index.htm"}},{"accession":"0001656472-26-000032","ticker":"CRON","company_name":"Cronos Group Inc.","filed_at":"2026-05-11T23:59:59+00:00","headline":"Cronos Q1 net revenue up 40% to $45.2M; authorizes $50M share buyback; CanAdelaar close extended to Sep 9","event_type":"earnings","sec_items":["1.01","2.02","8.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 8.01, 9.01","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001656472-26-000032","json":"https://secwatch.observer/filing/0001656472-26-000032.json","markdown":"https://secwatch.observer/filing/0001656472-26-000032.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1656472/000165647226000032/0001656472-26-000032-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1656472/000165647226000032/cron-20260508.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"Three Months Ended March 31, (In millions, except per share data and percentages) 2026 2025 Change Revenue $ 265.5 $ 227.8 17 % Gross margin 37.5 % 39.4 % Operating income (loss) $ (7.7) $ 1.8 NM Operating margin (2.9) % 0.8 % Net income $ 1.6 $ 3.8 (58) % Earnings per diluted share $ 0.04 $ 0.09 (56) %","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1111928/000111192826000094/0001111928-26-000094-index.htm","comparable_excerpt":"reference in such a filing or document. \n\n--- EX-99.1 (EX-99.1) ---\n\nCronos Group Reports 2026 First Quarter Results Net revenue in Q1 2026 increased by 40% year-over-year to $45.2 million Achieved record net revenue and gross profit in Q1 2026 Reached #1 market share in vapes in Canada 1 Ninth consecutive quarter of record net revenue in Israel, where PEACE","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1656472/000165647226000032/0001656472-26-000032-index.htm"}},{"accession":"0001827090-26-000017","ticker":"CERT","company_name":"Certara, Inc.","filed_at":"2026-05-11T23:59:59+00:00","headline":"Certara Q1 revenue $106.9M (+1%), net loss $8.8M; divests Regulatory Writing for $85M cash","event_type":"earnings","sec_items":["2.02","8.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 8.01, 9.01","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001827090-26-000017","json":"https://secwatch.observer/filing/0001827090-26-000017.json","markdown":"https://secwatch.observer/filing/0001827090-26-000017.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1827090/000182709026000017/0001827090-26-000017-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1827090/000182709026000017/certara-20260511.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"Three Months Ended March 31, (In millions, except per share data and percentages) 2026 2025 Change Revenue $ 265.5 $ 227.8 17 % Gross margin 37.5 % 39.4 % Operating income (loss) $ (7.7) $ 1.8 NM Operating margin (2.9) % 0.8 % Net income $ 1.6 $ 3.8 (58) % Earnings per diluted share $ 0.04 $ 0.09 (56) %","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1111928/000111192826000094/0001111928-26-000094-index.htm","comparable_excerpt":"First Quarter 2026 Results Total revenue for the first quarter of 2026 was $106.9 million, representing year-over-year growth of 1% on a reported basis. Software revenue for the first quarter of 2026 was $49.7 million, representing year-over-year growth of 7% on a reported basis. Services revenue for the first quarter of 2026 was $57.2 million, representing a year-over-year decrease of 4% on a reported basis . Total Bookings for the first quarter of 2026 were $115.3 million, representing a year-over-year decrease of 2%. Software Bookings for the first quarter of 2026 were $48.7 million, representing a year-over-year increase of 20%. The increase in software bookings was attributable to strong customer demand across our platform. Services Bookings for the first quarter of 2026 were $66.6 million, representing a year-over-year decrease of 14%. The decrease in services bookings was primarily driven by the timing of contract recognition and execution. Total cost of revenues for the first q","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1827090/000182709026000017/0001827090-26-000017-index.htm"}},{"accession":"0001193125-26-213371","ticker":"RPC","company_name":"Ridgepost Capital, Inc.","filed_at":"2026-05-08T23:59:59+00:00","headline":"Ridgepost Capital reports record AUM of $31B in Q1 2026, up 18% YoY","event_type":"earnings","sec_items":["2.02","7.01","8.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 8.01, 9.01","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-213371","json":"https://secwatch.observer/filing/0001193125-26-213371.json","markdown":"https://secwatch.observer/filing/0001193125-26-213371.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1841968/000119312526213371/0001193125-26-213371-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1841968/000119312526213371/rpc-20260507.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"Three Months Ended March 31, (In millions, except per share data and percentages) 2026 2025 Change Revenue $ 265.5 $ 227.8 17 % Gross margin 37.5 % 39.4 % Operating income (loss) $ (7.7) $ 1.8 NM Operating margin (2.9) % 0.8 % Net income $ 1.6 $ 3.8 (58) % Earnings per diluted share $ 0.04 $ 0.09 (56) %","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1111928/000111192826000094/0001111928-26-000094-index.htm","comparable_excerpt":"Ridgepost Capital, Inc (NYSE: RPC), a leading private markets solutions provider, today announced financial results for the first quarter ended March 31, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1841968/000119312526213371/0001193125-26-213371-index.htm"}},{"accession":"0001673985-26-000033","ticker":"ASIX","company_name":"AdvanSix Inc.","filed_at":"2026-05-08T23:59:59+00:00","headline":"AdvanSix Q1 net loss $15.5M; sales up 7% to $404M; declares $0.16 dividend; appoints new CFO","event_type":"earnings","sec_items":["2.02","8.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 8.01, 9.01","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001673985-26-000033","json":"https://secwatch.observer/filing/0001673985-26-000033.json","markdown":"https://secwatch.observer/filing/0001673985-26-000033.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1673985/000167398526000033/0001673985-26-000033-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1673985/000167398526000033/asix-20260508.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"Three Months Ended March 31, (In millions, except per share data and percentages) 2026 2025 Change Revenue $ 265.5 $ 227.8 17 % Gross margin 37.5 % 39.4 % Operating income (loss) $ (7.7) $ 1.8 NM Operating margin (2.9) % 0.8 % Net income $ 1.6 $ 3.8 (58) % Earnings per diluted share $ 0.04 $ 0.09 (56) %","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1111928/000111192826000094/0001111928-26-000094-index.htm","comparable_excerpt":"the second quarter.\" Summary first quarter 2026 financial results for the Company are included below: 1 ( $ in Thousands, Except Earnings Per Share) 1Q 2026 1Q 2025 (1) Sales $404,183 $377,791 Net Income (loss) (15,546) 23,344 Diluted Earnings Per Share (0.58) 0.86 Adjusted Diluted Earnings Per Share (2) (0.50) 0.93 Adjusted EBITDA (2) 4,756 51,626 Adjusted","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1673985/000167398526000033/0001673985-26-000033-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}